US 11406713
Xanthine oxidase inhibitor formulations
granted A61KA61K31/197A61K31/198
Quick answer
US patent 11406713 (Xanthine oxidase inhibitor formulations) held by XORTX THERAPEUTICS, INC. expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- XORTX THERAPEUTICS, INC.
- Grant date
- Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/197, A61K31/198, A61K31/375, A61K31/4188